After trialling a subscription-style system for procuring antimicrobial drugs, the UK’s National Health Service recently announced that it will formalise this approach to help spur research in this space. Historically, companies developing antimicrobial drugs have found it difficult to build revenues on these much-needed drugs considering antibiotic stewardship programs. This month’s cover story breaks down how such an approach could help address that.
Also, this month, we take a look at how the Swiss biotech landscape has weathered the tough financial ecosystem of last year, which continues to keep companies from listing on public exchanges.
Go deeper with GlobalData
Included in this issue is the latest coverage on oncology drug development following the American Society of Clinical Oncology 2024 Annual Meeting, and an interview on how patient advocacy is changing clinical research. All this, along with the latest news and deals in the pharmaceutical landscape.
Read the latest issue of Pharma Technology Focus for all this and insights, and analysis from the pharmaceutical industry
You can also subscribe here to receive email notifications when a new issue is available.
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Thank you!
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form
By GlobalData
